As of 2025-09-18, the Relative Valuation of InMed Pharmaceuticals Inc (IN.TO) is (6.45) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 4.19 CAD, the upside of InMed Pharmaceuticals Inc based on Relative Valuation is -253.8%.
The range of the Relative Valuation is (6.32) - (9.01) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 2.9x - 6.5x | 3.6x |
| Forward P/E multiples | 4.6x - 8.2x | 5.7x |
| Fair Price | (6.32) - (9.01) | (6.45) |
| Upside | -250.8% - -315.0% | -253.8% |
| Date | P/E |